Lumpinas, Stephanie .
HRN: 27-11-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2026
AMPICILLIN 1GM (VIAL)
06/06/2026
06/07/2026
IVT
2g
Q6
Thickly Msaf
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: